| scholarly article | Q13442814 |
| P6179 | Dimensions Publication ID | 1038003703 |
| P356 | DOI | 10.1038/BMT.2010.158 |
| P698 | PubMed publication ID | 20603623 |
| P2093 | author name string | A Yokoyama | |
| A Takeuchi | |||
| T Ikezoe | |||
| K Togitani | |||
| A Taniguchi | |||
| P2860 | cites work | The N-terminal domain of thrombomodulin sequesters high-mobility group-B1 protein, a novel antiinflammatory mechanism | Q33743664 |
| Engraftment syndrome following hematopoietic stem cell transplantation | Q34298239 | ||
| Thrombin Activatable Fibrinolysis Inhibitor, a Potential Regulator of Vascular Inflammation | Q46142052 | ||
| Protection of vascular barrier integrity by activated protein C in murine models depends on protease-activated receptor-1. | Q51732026 | ||
| Efficacy and safety of recombinant human soluble thrombomodulin (ART-123) in disseminated intravascular coagulation: results of a phase III, randomized, double-blind clinical trial | Q79292898 | ||
| Changes in vascular endothelial growth factor, angiopoietins, and Tie-2 levels with G-CSF stimulation in healthy donors | Q82967571 | ||
| P433 | issue | 4 | |
| P304 | page(s) | 616-618 | |
| P577 | publication date | 2010-07-05 | |
| P1433 | published in | Bone Marrow Transplantation | Q4941523 |
| P1476 | title | Recombinant human soluble thrombomodulin counteracts capillary leakage associated with engraftment syndrome | |
| P478 | volume | 46 |
| Q58793743 | Cytoprotective and pro-angiogenic functions of thrombomodulin are preserved in the C loop of the fifth epidermal growth factor-like domain |
| Q38315390 | Engraftment syndrome: double-edged sword of hematopoietic cell transplants |
| Q33677636 | G-protein coupled receptor 15 mediates angiogenesis and cytoprotective function of thrombomodulin |
| Q55301455 | Graft protective effect and induction of CD4+Foxp3+ cell by Thrombomodulin on allograft arteriosclerosis in mice. |
| Q38161835 | Pathogenesis of disseminated intravascular coagulation in patients with acute promyelocytic leukemia, and its treatment using recombinant human soluble thrombomodulin |
| Q40288619 | Sinusoidal obstruction syndrome after allogeneic hematopoietic stem cell transplantation: Incidence, risk factors and outcomes. |
| Q51488433 | The fifth epidermal growth factor-like region of thrombomodulin exerts cytoprotective function and prevents SOS in a murine model. |
| Q51051596 | Thrombomodulin alleviates murine GVHD in association with an increase in the proportion of regulatory T cells in the spleen. |
| Q38100652 | Thrombomodulin and the vascular endothelium: insights into functional, regulatory, and therapeutic aspects |
| Q51453803 | Thrombomodulin blocks calcineurin inhibitor-induced vascular permeability via inhibition of Src/VE-cadherin axis. |
| Q38364209 | Thrombomodulin/activated protein C system in septic disseminated intravascular coagulation |
Search more.